No. | Study | Random sequence generation (selection bias) | Allocation concealment (selection bias) | Blinding of participants and personnel (performance bias) | Blinding of outcome assessments (detection bias) | Incomplete outcome data (attrition bias) | Selective reporting (reporting bias) | Other bias |
---|---|---|---|---|---|---|---|---|
1 | Kong et al. 2014 [43] | Unclear | N/Ac | N/Ac | N/Ac | High risk a | Low risk | No |
2 | Haro et al. 2015 [44] | Low risk | Low risk | N/Ad | N/Ad | Low risk | Low risk | No |
3 | Haro et al. 2016 [37] | Low risk | Low risk | N/Ad | N/Ad | Low risk | Low risk | No |
4 | Haro et al. 2017 [38] | Low risk | Low risk | N/Ad | N/Ad | Low risk | Low risk | No |
5 | Djuric et al. 2017 [41] | Low risk | Low risk | N/Ad | N/Ad | Low risk | Low risk | No |
6 | Luisi et al. 2019 [45] | Unclear | N/Ac | N/Ac | N/Ac | Low risk | Low risk | No |
7 | Pagliai et al. 2019 [46] | Low risk | Low risk | N/Ad | N/Ad | Low risk | Low risk | No |
8 | Ghosh et al. 2020 [47] | Unclear | N/Ae | N/Ae | N/Ae | Low risk | Low risk | No |
9 | Pisanu et al. 2020 [48] | Unclear | N/Ae | N/Ae | N/Ae | Low risk | Low risk | No |
10 | Zhu et al. 2020 [49] | Low risk | Low risk | N/Ad | N/Ad | Low risk | Low risk | No |
11 | Galié et al. 2021 [34] | Low risk | Low risk | N/Ad | N/Ad | Low risk | Low risk | No |
12 | Galié et al. 2021 [35] | Low risk | Low risk | N/Ad | N/Ad | Low risk | Low risk | No |
13 | Ismael et al. 2021 [39] | Unclear | N/Ae | N/Ae | N/Ae | Low risk | Low risk | No |
14 | Muralidharan et al. 2021 [50] | Low risk | Low risk | N/Ad | N/Ad | Low risk | Low risk | No |
15 | Rejeski et al. 2021 [51] | Unclear | N/Ae | N/Ae | N/Ae | Low risk | Low risk | No |
16 | Babrber et al. 2021 [52] | Low risk | Low risk | N/Ad | N/Ad | Low risk | Low risk | No |
17 | Choo et al. 2023 [42] | Unclear | Low risk | N/Ad | N/Ad | Low risk | Low risk | No |
18 | Boughanema et al. 2023 [36] | Unclear | N/Ae | N/Ae | N/Ae | Low risk | Low risk | No |
19 | Gómez-Pérez et al. 2023 [40] | Unclear | Low risk | N/Ad | N/Ad | Low risk | Low risk | No |
20 | Shoer et al. 2023 [53] | High riskb | Low risk | N/Ad | N/Ad | Low risk | Low risk | No |